Patent details

300539 Product Name: Ofatumumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300539
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1558648
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
300539
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/10/625/001-002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
21/04/2010
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
09/07/2012
First Marketing Authorization date:
21/04/2010
Grant date:
22/06/2017
Activation date:
17/10/2023
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
09/07/2012
SPC/SPC Extension Expiration Date:
20/04/2025
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
09/07/2012
 
 

 

Name:
Genmab A/S
Address:
Bredgade 34 P.O. Box 9068, 1260 COPENHAGEN K, Denmark (DK)

Agent

Name:
ir. F.A. Geurts c.s.
From:
09/07/2012
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
18/21
Publication date:
12/05/2021
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
26/17
Publication date:
28/06/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
2012/28
Publication date:
11/07/2012
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/10/2023
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
20/04/2021 SPC Documents Annex SPC 1 PDF /9/3/5/0/0/0400300539/docs/300539_3_supplprotectioncertificate20210420110126084.pdf
20/04/2021 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /9/3/5/0/0/0400300539/docs/300539_16_incomingcorrespondencepaper20210420110103810.pdf
22/06/2017 Outgoing Correspondence Decision grant 2 PDF /9/3/5/0/0/0400300539/docs/300539_2_outgoingcorrespondence20170623023016613.pdf
22/06/2017 SPC Documents Certificate SPC 1 PDF /9/3/5/0/0/0400300539/docs/300539_20_supplprotectioncertificate20170623023016701.pdf
06/06/2017 Examination Internal New 31 PDF /9/3/5/0/0/0400300539/docs/300539_22_examination20170606144602279.pdf
15/03/2017 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /9/3/5/0/0/0400300539/docs/300539_14_incomingcorrespondencepaper20210310044945919.pdf
06/10/2016 SPC Documents Decision SPC 9 PDF /9/3/5/0/0/0400300539/docs/300539_7_supplprotectioncertificate20161007045619138.pdf
06/10/2016 Outgoing Correspondence Letter to applicant 1 PDF /9/3/5/0/0/0400300539/docs/300539_10_outgoingcorrespondence20161007045619052.pdf
26/09/2014 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /9/3/5/0/0/0400300539/docs/300539_9_incomingcorrespondencepaper20210310044627888.pdf
26/09/2014 SPC Documents Annex SPC 16 PDF /9/3/5/0/0/0400300539/docs/300539_23_supplprotectioncertificate20210310044627960.pdf
23/06/2014 Outgoing Correspondence Outgoing Letter 1 PDF /9/3/5/0/0/0400300539/docs/300539_8_outgoingcorrespondence20140623.pdf
23/06/2014 Outgoing Correspondence Outgoing Letter 1 PDF /9/3/5/0/0/0400300539/docs/300539_21_outgoingcorrespondence20140623.pdf
04/06/2014 SPC Documents Annex SPC 2 PDF /9/3/5/0/0/0400300539/docs/300539_0_supplprotectioncertificate20200925042246184.pdf
04/06/2014 Incoming Correspondence Paper Accompanying letter incoming document 6 PDF /9/3/5/0/0/0400300539/docs/300539_5_incomingcorrespondencepaper20210310044102312.pdf
04/06/2014 Incoming Correspondence Paper Other 13 PDF /9/3/5/0/0/0400300539/docs/300539_19_incomingcorrespondencepaper20140604.pdf
08/04/2014 Outgoing Correspondence Outgoing Letter 2 PDF /9/3/5/0/0/0400300539/docs/300539_11_outgoingcorrespondence20140408.pdf
03/04/2014 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /9/3/5/0/0/0400300539/docs/300539_15_incomingcorrespondencepaper20210310043909718.pdf
25/06/2013 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /9/3/5/0/0/0400300539/docs/300539_6_incomingcorrespondencepaper20210310043710941.pdf
10/07/2012 Outgoing Correspondence Outgoing Letter 1 PDF /9/3/5/0/0/0400300539/docs/300539_18_outgoingcorrespondence20120710.pdf
09/07/2012 SPC Documents Accompanying letter SPC 1 PDF /9/3/5/0/0/0400300539/docs/300539_1_supplprotectioncertificate20200925032535399.pdf
09/07/2012 SPC Documents Annex SPC 4 PDF /9/3/5/0/0/0400300539/docs/300539_4_supplprotectioncertificate20200925032206863.pdf
09/07/2012 SPC Documents Marketing Authorization SPC 4 PDF /9/3/5/0/0/0400300539/docs/300539_12_supplprotectioncertificate20200925030648804.pdf
09/07/2012 Application Form First filed application form 3 PDF /9/3/5/0/0/0400300539/docs/300539_13_applicationform20120709.pdf
09/07/2012 SPC Documents Summary of the characteristics of the product 15 PDF /9/3/5/0/0/0400300539/docs/300539_17_supplprotectioncertificate20200925030956642.pdf